𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

✍ Scribed by Youxue Zhang; Lei Yao; Xianyu Zhang; Hongfei Ji; Lihong Wang; Shanshan Sun; Da Pang

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
433 KB
Volume
137
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

JAM-A expression positively correlates w
JAM-A expression positively correlates with poor prognosis in breast cancer patients
✍ Elaine A. McSherry; Sharon F. McGee; Karin Jirstrom; Emma M. Doyle; Donal J. Bre πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 367 KB

## Abstract The cell–cell adhesion protein junctional adhesion molecule‐A (JAM‐A) influences epithelial cell morphology and migration. As migration is required for tumor cell invasion and metastasis, we sought to elucidate the role of JAM‐A in invasive breast cancer. A breast cancer tissue microarr

Expression of maspin predicts poor progn
Expression of maspin predicts poor prognosis in breast-cancer patients
✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 365 KB

## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin

Vimentin expression is not associated wi
Vimentin expression is not associated with poor prognosis in breast cancer
✍ Ram Seshadri; Wendy A. Raymond; Anthony S.-Y. Leong; David J. Horsfall; Kieran M πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 483 KB πŸ‘ 2 views

The clinical significance of vimentin intermediate filament (VIF) expression was studied in relation to other established prognostic parameters in primary breast cancer. Archival tumour samples embedded in paraffin were examined by immunohistochemistry with monoclonal antibodies (MAbs) to VIF, p53 p